Cargando…

Fas/Fas ligand regulation mediates cell death in human Ewing's sarcoma cells treated with melatonin

BACKGROUND: Despite recent advances in cancer therapy, the 5-year survival rate for Ewing's sarcoma is still very low, and new therapeutic approaches are necessary. It was found previously that melatonin induces cell death in the Ewing's sarcoma cell line, SK-N-MC, by activating the extrin...

Descripción completa

Detalles Bibliográficos
Autores principales:	García-Santos, G, Martin, V, Rodríguez-Blanco, J, Herrera, F, Casado-Zapico, S, Sánchez-Sánchez, A M, Antolín, I, Rodríguez, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Translational Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314785/ https://www.ncbi.nlm.nih.gov/pubmed/22382690 http://dx.doi.org/10.1038/bjc.2012.66

Ejemplares similares

Abundant Fas expression by gastrointestinal stromal tumours may serve as a therapeutic target for MegaFasL
por: Rikhof, B, et al.
Publicado: (2008)

Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression
por: Yamana, K, et al.
Publicado: (2005)

Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation
por: Minas, V, et al.
Publicado: (2007)

Melatonin-induced methylation of the ABCG2/BCRP promoter as a novel mechanism to overcome multidrug resistance in brain tumour stem cells
por: Martín, V, et al.
Publicado: (2013)

Fenretinide-dependent upregulation of death receptors through ASK1 and p38α enhances death receptor ligand-induced cell death in Ewing's sarcoma family of tumours
por: White, D E, et al.
Publicado: (2010)

Tumour-induced apoptosis in human mesothelial cells: a mechanism of peritoneal invasion by Fas Ligand/Fas interaction
por: Heath, R M, et al.
Publicado: (2004)

Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling
por: Han, Sheng, et al.
Publicado: (2017)

Caspase-8 expression is predictive of tumour response to death receptor 5 agonist antibody in Ewing's sarcoma
por: Kang, Zhigang, et al.
Publicado: (2015)

Impairment of Fas-ligand–caveolin-1 interaction inhibits Fas-ligand translocation to rafts and Fas-ligand-induced cell death
por: Glukhova, Xenia A., et al.
Publicado: (2018)

Ewing sarcoma dissemination and response to T-cell therapy in mice assessed by whole-body magnetic resonance imaging
por: Liebsch, L, et al.
Publicado: (2013)

Melatonin Cytotoxicity Is Associated to Warburg Effect Inhibition in Ewing Sarcoma Cells
por: Sanchez-Sanchez, Ana M., et al.
Publicado: (2015)

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand
Publicado: (1996)

Fas–Fas Ligand: Checkpoint of T Cell Functions in Multiple Sclerosis
por: Volpe, Elisabetta, et al.
Publicado: (2016)

The ganglioside antigen G(D2) is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting
por: Kailayangiri, S, et al.
Publicado: (2012)

Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids
Publicado: (1995)

Melatonin partially protects 661W cells from H(2)O(2)-induced death by inhibiting Fas/FasL-caspase-3
por: Sánchez-Bretaño, Aída, et al.
Publicado: (2017)

Inhibitory effects of pharmacological doses of melatonin on aromatase activity and expression in rat glioma cells
por: González, A, et al.
Publicado: (2007)

Understanding the role of Fas-Fas ligand system in bone
por: Marusic, Ana, et al.
Publicado: (2012)

Differential expressions of Fas and Fas ligand in human placenta.
por: Roh, Cheong-Rae, et al.
Publicado: (2002)

PI3K/AKT is involved in mediating survival signals that rescue Ewing tumour cells from fibroblast growth factor 2-induced cell death
por: Hotfilder, M, et al.
Publicado: (2005)

Sigma-2 ligands induce tumour cell death by multiple signalling pathways
por: Zeng, C, et al.
Publicado: (2012)

Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-β expression
por: Houston, A, et al.
Publicado: (2003)

Involvement of the Fas and Fas ligand in testicular germ cell apoptosis by zearalenone in rat
por: Jee, Youngheun, et al.
Publicado: (2010)

Expression Profile of Fas-Fas Ligand in Spiral Ganglion Cells During Apoptosis
por: Gu, Tae Woo, et al.
Publicado: (2014)

Downregulation of Bcl-2 sensitises interferon-resistant renal cancer cells to Fas
por: Kelly, J D, et al.
Publicado: (2004)

MicroRNA-181c prevents apoptosis by targeting of FAS receptor in Ewing’s sarcoma cells
por: Kawano, Masanori, et al.
Publicado: (2018)

The Fas/Fas Ligand Death Receptor Pathway Contributes to Phenylalanine-Induced Apoptosis in Cortical Neurons
por: Huang, Xiaodong, et al.
Publicado: (2013)

Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus
por: Vincent, Fabien B, et al.
Publicado: (2020)

Fas and Fas Ligand Interactions Suppress Melanoma Lung Metastasis
por: Owen-Schaub, Laurie B., et al.
Publicado: (1998)

Apoptosis role of FAS/FAS ligand system in the regulation of myelopoiesis.
por: Alenzi, Faris Q., et al.
Publicado: (2005)

Prognostic value of the Fas/Fas ligand system in breast cancer
por: Bębenek, Marek, et al.
Publicado: (2013)

MS-275 sensitizes osteosarcoma cells to Fas ligand-induced cell death by increasing the localization of Fas in membrane lipid rafts
por: Rao-Bindal, K, et al.
Publicado: (2012)

Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway
por: Atsuta, Ikiru, et al.
Publicado: (2013)

Specific recognition and inhibition of Ewing tumour growth by antigen-specific allo-restricted cytotoxic T cells
por: Thiel, U, et al.
Publicado: (2011)

Mechanisms Involved in the Pro-Apoptotic Effect of Melatonin in Cancer Cells
por: Rodriguez, Carmen, et al.
Publicado: (2013)

Soluble Fas and the −670 Polymorphism of Fas in Lupus Nephritis
por: Bollain-y-Goytia, Juan José, et al.
Publicado: (2014)

FAS and FAS-Ligand Promoter Polymorphisms in Hepatitis B Virus Infection
por: Mohammadi, Asadollah, et al.
Publicado: (2015)

The relationship between Fas and Fas ligand gene polymorphism and preeclampsia risk
por: Wang, Tingting, et al.
Publicado: (2019)

Fas ligand mediates activation-induced cell death in human T lymphocytes
Publicado: (1995)

Fas cell surface death receptor/Fas ligand genetic variants in gastric cancer patients: A case-control study
por: Asgari, Rezvan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s1je8i5khpr00b8r4a7ld84fki